Dr. Symmans on the Staging System for Breast Cancer

William F. Symmans, MD
Published: Thursday, Sep 14, 2017



William F. Symmans, MD, professor of Pathology, The University of Texas MD Anderson Cancer Center, discusses the staging system for patients with breast cancer.

With the anticipated 8th addition of the staging system, a current question is what is to be expected in the staging setting? A lot of attention has been placed in the post-neoadjuvant staging, discusses Symmans.

We can anticipate greater clarity for the practicing pathologists and more solid guidelines for defining how to measure tumor burden in the challenging area of breast pathology going forward, explains Symmans.



William F. Symmans, MD, professor of Pathology, The University of Texas MD Anderson Cancer Center, discusses the staging system for patients with breast cancer.

With the anticipated 8th addition of the staging system, a current question is what is to be expected in the staging setting? A lot of attention has been placed in the post-neoadjuvant staging, discusses Symmans.

We can anticipate greater clarity for the practicing pathologists and more solid guidelines for defining how to measure tumor burden in the challenging area of breast pathology going forward, explains Symmans.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Publication Bottom Border
Border Publication
x